menu
    • menu

    Company profile for Eilean Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Eilean Therapeutics is a small molecule oncology drug discovery company that is committed to improving the lives of cancer patients by defeating cancer. Many cancers develop resistance to treatment either by developing mutations or escape mechanisms, thereby limiting the activity of current therapeutics. By developing pan-variant therapies that target the major drivers of cancer resistance, we are overcoming the limitations o...
    Eilean Therapeutics is a small molecule oncology drug discovery company that is committed to improving the lives of cancer patients by defeating cancer. Many cancers develop resistance to treatment either by developing mutations or escape mechanisms, thereby limiting the activity of current therapeutics. By developing pan-variant therapies that target the major drivers of cancer resistance, we are overcoming the limitations of current oncology therapeutics and developing best-in-class therapeutics for hematologic malignancies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Eilean TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3500 S Dupont Hwy Dover, DE 19901
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.eileanther.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Eilean Pharma Unveils TE205 MALT1 Degrader Efficacy
    Eilean Pharma Unveils TE205 MALT1 Degrader Efficacy

    05 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/eilean-therapeutics-presents-first-in-class-malt1-degrader-te205-demonstrating-in-vivo-efficacy-in-ulcerative-colitis-at-the-4th-international-conference-on-microbiology-and-immunology-302604708.html

    PR NEWSWIRE
    05 Nov 2025
    Share Share
    Chemdiv Extends Partnership With Mondego Bio On PTPN2 Program
    Chemdiv Extends Partnership With Mondego Bio On PTPN2 Program

    24 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/chemdiv-extends-discovery-and-early-development-partnership-with-mondego-bio-on-best-in-class-ptpn2-immuno-oncology-program-302593824.html

    PR NEWSWIRE
    24 Oct 2025
    Share Share
    Eilean Therapeutics Present Brain-Permeable CDK2 Inhibitor
    Eilean Therapeutics Present Brain-Permeable CDK2 Inhibitor

    16 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/eilean-therapeutics-presents-novel-selective-brain-permeable-cdk2-inhibitor-for-treatment-of-ccne1-dependent-cancers-302586199.html

    PR NEWSWIRE
    16 Oct 2025
    Share Share
    Eilean Present Pan-EGFR Inhibitor ZE77-0273 For EGFR-Mutant NSCLC
    Eilean Present Pan-EGFR Inhibitor ZE77-0273 For EGFR-Mutant NSCLC

    13 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/eiiean-therapeutics-presents-novel-wild-type-sparing-reversible-pan-egfr-inhibitor-ze77-0273-with-broad-activity-against-resistance-mutations-in-egfr-mutant-nsclc-at-aacr-nci-eortc-international-conference-on-molecular-targets--302582474.html

    PR NEWSWIRE
    13 Oct 2025
    Share Share
    Lomond Therapeutics Report Results for Lonitoclax, BCL-2 Inhibitor
    Lomond Therapeutics Report Results for Lonitoclax, BCL-2 Inhibitor

    09 Dec 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/lomond-therapeutics-reports-results-from-ongoing-clinical-studies-of-lonitoclax-a-selective-bcl-2-inhibitor-with-best-in-class-selectivity-versus-bcl-xl-and-no-cyp-3a4-liability-302325763.html

    PR NEWSWIRE
    09 Dec 2024
    Share Share
    Lomond Therapeutics Announces FDA Clearance For Lonitoclax Study
    Lomond Therapeutics Announces FDA Clearance For Lonitoclax Study

    15 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/lomond-therapeutics-announces-fda-clearance-of-ind-application-for-phase-1-study-of-lonitoclax-a-selective-bcl2-inhibitor-for-chronic-lymphocytic-leukemia-small-lymphocytic-lymphoma-and-select-low-grade-lymphomas-302275587.html

    PR NEWSWIRE
    15 Oct 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search